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Volume 60, Number 4 Raux et al 863performed at high-volume centers, our results may not be
generalizable to other centers with lower surgical volume.
CONCLUSIONS
In this propensity-matched series, FEVAR was associ-
ated with a higher mortality and an “any complication”
occurrence compared with OSR, highlighting that OSR
should be considered preferable to FEVAR for the low-
risk patient with a CAAA. Mesenteric infarction was the
principal cause of death after FEVAR. Identifying patients
with potential target vessel difﬁculties or graft complica-
tions might identify patients at risk for FEVAR. Thereby,
the extension of the infrarenal AAA treatment paradigm
shift to EVAR cannot be applied to a similar paradigm shift
of CAAA to FEVAR. Prospective studies will help to deter-
mine beneﬁts of FEVAR over OSR.
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Submitted Nov 13, 2013; accepted Apr 3, 2014.DISCUSSIONDr Gustavo Oderich (Rochester, Minn). I rise here because
your results are markedly different than what has been reported
in numerous publications, including meta-analyses, systematic re-
views, prospective studies, and national data sets. Clearly bothoperationsdopen or fenestrated repairdrequire a set of skills
and a learning curve that has to be mastered for one to achieve
outstanding results. Case selection, planning, and multidisciplinary
postoperative care can have great impact on early outcomes of
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learning curve and skill set which has been achieved at the Massa-
chusetts General Hospital (MGH) with open repair of hundreds of
patients with juxtarenal, suprarenal, and thoracoabdominal aneu-
rysms over decades, has also been achieved with the ﬁrst 50 fenes-
trated cases done at your center. Clearly, at least in our experience,
I think fenestrated repair does require a learning curve, planning,
case selection, and mastering a set of skillsdeven for those that
are already skilled and experienced with other types of endovascu-
lar procedures.
The other particular question pertain the cause of death,
which in most patients was mesenteric ischemia. Do you think
this was due to embolization or ischemia from narrow or occluded
stents? We now stent all single-diameter scallops. I’ll tell you that
at least in our experience, scallops of 10-mm diameter may be asso-
ciated with mesenteric ischemia, and the safest is probably to stent
liberally.
Dr Maxime Raux. One of the major causes of death was not
mesenteric ischemia but infarction due to multiple embolisms after
catheterization, but no superior mesenteric artery was thrombosed
after the procedure. And when we made computed tomography
scans for the patients, all superior mesenteric arteries were patent,
but it is probably related to multiple emboli.
Dr John Ricotta (Washington, D.C.). That was a very nice
paper. If I interpreted correctly, what it says is if you have a patient
that is suitable for open repair, that fenestrated repair offers no
beneﬁt and may be worse. But it doesn’t address the issue of the
patient who is not suited for open repair. You had about 15 of
your patients in the fenestrated group who were not propensity
matched, so I assume that they didn’t match with anybody inthe open group. Could you tell us what happened to those pa-
tients? Could you tell us whether the mortality rate in the open
group that was not propensity matched was the same as in the pro-
pensity-matched group so that we can get some idea about that?
Dr Raux. The mortality rate in the open group was mostly the
same, but in the fenestrated endovascular repair group (FEVAR)
group, on the unmatched patient, the mortality rate was higher,
with 10.5% mortality for the unmatched patient. Maybe Professor
Becquemin would like to comment.
Dr Jean-Pierre Becquemin (Créteil, France). I have some
comments. First, I want to congratulate Maxime for this very
important work and also my colleagues from MGH for the
outstanding results. Obviously, we were disappointed by our
own results with FEVAR, which resulted in a higher than expected
mortality rate. As mentioned, this mortality rate was mostly related
to multiple atherosclerotic embolisms. It was probably a mistake to
treat some of these patients with FEVAR.
Lessons can be drawn from this study: (1) surgery can give
excellent results in expert hands, and (2) FEVAR is not an easy
procedure. It may be very tricky, even if you carefully select pa-
tients. Sometimes the target vessels, the aorta, or the access vessels
are not suitable and pushing the limits of indications may end up in
catastrophe.
Finally, I think that FEVAR has obviously a future since stent
graft technology will improve as well as the skill of surgeons per-
forming these procedures. The key selection criterion, in my
opinion, is not patients’ general status (high risk for FEVAR,
low risk for open repair), but more the anatomical suitability of
vessels. With a proper selection, results of FEVAR will probably
equal the results of open surgery in the near future.
